Fieldex Exploration to acquire Copeland Biosciences.

Synopsis

Fieldex Exploration, a Canadian mineral exploration firm, to acquire Copeland Biosciences, a cannabis pharma company, in a reverse takeover transaction. Upon the deal closure, Fieldex will be listed on the Canadian Securities Exchange and will be renamed Copeland Biosciences Corp.

Principals

target

Copeland Biosciences

bidder

Fieldex Exploration

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

glenn copeland

CEO at COPELAND BIOSCIENCES

Manager

target

Deal

n/a

Total Value

Bidder Team (1)

martin dallaire

President and CEO at FIELDEX EXPLORATION

Manager

bidder

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy